United States · Funded startup

Who invested in Cartesian Therapeutics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$180Mraised across 2 rounds since 2024, from 2 sources

$130MRound$50MDebt
Latest round
Debt, $50MMay 2026
Biggest round
$130MRound · Jul 2024
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$130MRound$50MDebt
First round
Round, $130M
Jul 2024
Biggest round
$130M
Round · Jul 2024
Between rounds
22 months
from the last two

The rounds

  1. May 2026
    Debt$50M1 returning

    Source recorded

  2. Jul 2024
    Round$130M2 new

    Source recordedSEC filing: $130M sold, first sale Jul 2024

Founders and team

From Cartesian Therapeutics's own website: 2 on the team.

  • Blaine DavisChief Financial Officer
  • Peter TraberHead of Research and Development

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

InvusPrivate equity2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cartesian Therapeutics

Who invested in Cartesian Therapeutics?

Cartesian Therapeutics's investors include Invus and National Heart, Lung and Blood Institute.

How much has Cartesian Therapeutics raised?

Cartesian Therapeutics has raised $180M across 2 rounds since 2024.

When did Cartesian Therapeutics last raise?

Cartesian Therapeutics's most recent round was a Debt of $50M in May 2026.

What was Cartesian Therapeutics's biggest round?

Cartesian Therapeutics's largest round on record is $130M (Undisclosed round), in Jul 2024.

Who backed Cartesian Therapeutics first?

Cartesian Therapeutics's first round on record, in Jul 2024, was backed by Invus and National Heart, Lung and Blood Institute.

What stage is Cartesian Therapeutics at?

Cartesian Therapeutics's latest named round is a Debt, in May 2026.

Where is Cartesian Therapeutics based?

Cartesian Therapeutics is based in the United States.

Companies like Cartesian Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.